C07D 215/16
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
C07D215/16 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 5,592 US grants and 4,994 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,592
- Published applications
- 4,994
- Assignees
- 2,081
- Inventors
- 15,523
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 56 | 0 |
| 1977 | 67 | 0 |
| 1978 | 42 | 0 |
| 1979 | 38 | 0 |
| 1980 | 44 | 0 |
| 1981 | 51 | 0 |
| 1982 | 43 | 0 |
| 1983 | 53 | 0 |
| 1984 | 65 | 0 |
| 1985 | 69 | 0 |
| 1986 | 80 | 0 |
| 1987 | 77 | 0 |
| 1988 | 99 | 0 |
| 1989 | 92 | 0 |
| 1990 | 110 | 0 |
| 1991 | 106 | 0 |
| 1992 | 84 | 0 |
| 1993 | 123 | 0 |
| 1994 | 91 | 0 |
| 1995 | 117 | 0 |
| 1996 | 113 | 0 |
| 1997 | 134 | 0 |
| 1998 | 123 | 0 |
| 1999 | 103 | 0 |
| 2000 | 104 | 0 |
| 2001 | 122 | 19 |
| 2002 | 136 | 141 |
| 2003 | 132 | 185 |
| 2004 | 116 | 258 |
| 2005 | 98 | 265 |
| 2006 | 144 | 255 |
| 2007 | 125 | 235 |
| 2008 | 127 | 242 |
| 2009 | 160 | 239 |
| 2010 | 134 | 271 |
| 2011 | 160 | 204 |
| 2012 | 167 | 215 |
| 2013 | 186 | 192 |
| 2014 | 187 | 262 |
| 2015 | 214 | 216 |
| 2016 | 145 | 180 |
| 2017 | 154 | 171 |
| 2018 | 124 | 181 |
| 2019 | 153 | 168 |
| 2020 | 132 | 207 |
| 2021 | 141 | 173 |
| 2022 | 116 | 163 |
| 2023 | 96 | 177 |
| 2024 | 90 | 160 |
| 2025 | 94 | 121 |
| 2026 | 55 | 94 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH29 Sep 2026US 12,747,221 B2Emory Univeristy
- Methods and compositions for treating cancer22 Sep 2026US 12,740,976 B2City of Hope
- Lipoxygenase inhibitors22 Sep 2026US 12,741,926 B2SRI International
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Crystalline forms of 3-(5,7-difluoro-4-oxo-1,4-dihydroquinolin-2-yl)-4-(methylsulfonyl)benzonitrile8 Oct 2026US 2026/0308126 A1
- Antidegradant bis(dihydro and tetrahydroquinoline) compounds and uses thereof8 Oct 2026US 2026/0308127 A1Flexsys IP Holdings, LLC
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Hydroxylamine-based bcr-abl1 inhibitors for treatment of cancer1 Oct 2026US 2026/0297031 A1University of Georgia Research Foundation, Inc.
- Quinolineimine antidegradant compounds and uses thereof24 Sep 2026US 2026/0285812 A1Flexsys IP Holdings, LLC
Most cited
By later US patents
- Material for luminescence element and luminescence element using the same890US 6,528,187 B1Fuji Photo Film Co., Ltd. · 2003
- 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use451US 4,689,338 ARiker Laboratories, Inc. · 1987
- Substituted unsymmetrical cyanine dyes with selected permeability384US 5,658,751 AMolecular Probes, Inc. · 1997
- Cyclic-substituted unsymmetrical cyanine dyes371US 5,436,134 AMolecular Probes, Inc. · 1995
- 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines350US 5,389,640 AMinnesota Mining and Manufacturing Company · 1995